GGrantIndex
Sort

40,608 grants matching prostate cancer

Methylation and mutations in RB1 and variants of synthetic folic acid metabolism

$356,170
Manuela A Orjuela · Columbia University Health Sciences · R01 · FY2018 · CA

Molecular biomarkers of selenium chemoprevention

$356,152
Clement C Ip · Roswell Park Cancer Institute Corp · R01 · FY2006 · CA

Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer

$356,152
Daniel Edward Frigo · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

The Molecular Profile of Prostate Tumors in African-American Men

$356,143
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Quantitiative MRI of prostate cancer as a biomarker and guide for treatment

$356,128
Fiona Fennessy · Brigham And Women'S Hospital · U01 · FY2011 · CA

Proteases in Prostate Cancer Bone Metastasis

$356,113
Michael L Cher · Wayne State University · R01 · FY2007 · DK

CXCL13: a mediator of prostate cancer progression

$356,098
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2018 · CA

CXCL13: a mediator of prostate cancer progression

$356,098
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2015 · CA

CXCL13: a mediator of prostate cancer progression

$356,098
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2016 · CA

CXCL13: a mediator of prostate cancer progression

$356,098
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2017 · CA

Nutrition, Metabolism, and Cancer

$356,089
Regina G Ziegler · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets

$356,084
James A Wells · University Of California, San Francisco · R01 · FY2023 · CA

New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets

$356,084
James A Wells · University Of California, San Francisco · R01 · FY2022 · CA

GREATER DENVER LATINO CANCER PREVENTION/CONTROL NETWORK

$356,073
University Of Colorado Denver/Hsc Denver · U01 · FY2001 · CA

Angiogenin-induced RNA cleavage in cancer

$356,063
Paul J. Anderson · Brigham And Women'S Hospital · R01 · FY2013 · CA

Interaction of germline and somatic changes in PCa progression

$356,039
Wennuan Liu · Wake Forest University Health Sciences · R01 · FY2012 · CA

Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer

$356,033
Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2019 · CA

Prevention and Treatment of Impotence

$356,025
University Of California San Francisco · R37 · FY2005 · DK

Prevention and Treatment of Impotence

$356,025
University Of California San Francisco · R37 · FY2004 · DK

G-protein-coupled receptor signaling in cancer development and treatment

$356,016
Ramiro Iglesias-Bartolome · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Collaborative Research: Functionalized Nano-textured Surfaces to Isolate and Identify Bladder Cancer Cells

$356,000
Samir M Iqbal · University Of Texas At Arlington · · FY2014 · ENG

SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE

$355,982
Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2019 · CA

The Role of Fbxw7 in genetic instability and cancer

$355,982
Jian-Hua Mao · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2009 · CA

The Role of Fbxw7 in genetic instability and cancer

$355,982
Jian-Hua Mao · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2010 · CA

Novel Insights in the regulation of HIF1alpha Stability

$355,974
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA